SpringWorks Therapeutics Inc. (SWTX) NASDAQ
$46.45 0.92 (2.02%)
Market Cap: $3.36B
As of 04/29/24 04:00 PM EDT. Market closed.
SpringWorks Therapeutics Inc. (SWTX)
NASDAQ
$46.45
0.92 (2.02%)
Market Cap: $3.36B
As of 04/29/24 04:00 PM EDT. Market closed.
Add to Portfolio
springworks therapeutics is a mission-driven medicines company dedicated to developing innovative potential new treatments for unserved and underserved patient communities. originally conceived by pfizer, springworks presents a groundbreaking new model for collaboration rooted in connecting scientists, biopharmaceutical partners, patient groups, funders and philanthropists to advance and deliver ... read more
COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO
Saqib Islam
Full Time Employees
261
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO
Saqib Islam
Full Time Employees
261
Address
100 Washington Boulevard, CT, Stamford, 06902.
PRICE CHART FOR SPRINGWORKS THERAPEUTICS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$46.55
Previous Close
$45.53
Days Range
$45.47 - $47.25
52 week range
$18 - $53.92
Volume
795,611
Avg. Volume (30 days)
777,740
Market Cap
$3.36B
Dividend Yield
-
P/E
-
Shares Outstanding
73,786,845
Open
$46.55
Previous Close
$45.53
Days Range
$45.47 - $47.25
52 week range
$18 - $53.92
Volume
795,611
Avg. Volume (30 days)
777,740
Market Cap
$3.36B
Dividend Yield
-
P/E
-
Shares Outstanding
73,786,845
FINANCIAL STATEMENTS FOR SPRINGWORKS THERAPEUTICS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR SPRINGWORKS THERAPEUTICS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Ashar Bhavesh | Chief Commercial Officer | Apr 01, 2024 | Option Exercise | $47.62 | 1,824 | 86,859 | 56,330 | Apr 03, 2024, 04:01 PM |
| Pichl Daniel | Chief People Officer | Feb 16, 2024 | Option Exercise | $27.64 | 15,000 | 414,600 | 60,212 | Feb 20, 2024, 06:56 PM |
| Pichl Daniel | Chief People Officer | Feb 16, 2024 | Sale | $50.10 | 15,000 | 751,549 | 45,212 | Feb 20, 2024, 06:56 PM |
| Ashar Bhavesh | Chief Commercial Officer | Feb 05, 2024 | Sale | $49.32 | 4,834 | 238,435 | 58,154 | Feb 05, 2024, 09:24 PM |
| Ashar Bhavesh | Chief Commercial Officer | Feb 02, 2024 | Sale | $44.37 | 3,222 | 142,976 | 65,121 | Feb 05, 2024, 09:24 PM |
| Pichl Daniel | Chief People Officer | Feb 02, 2024 | Option Exercise | $27.64 | 16,250 | 449,150 | 71,393 | Feb 05, 2024, 09:23 PM |
| Pichl Daniel | Chief People Officer | Feb 02, 2024 | Sale | $44.32 | 26,181 | 1,160,362 | 62,127 | Feb 05, 2024, 09:23 PM |
| Weinstein Herschel S | General Counsel & Secretary | Jan 08, 2024 | Option Exercise | $41.53 | 2,423 | 100,627 | 52,239 | Jan 08, 2024, 09:13 PM |
| Weinstein Herschel S | General Counsel & Secretary | Jan 05, 2024 | Option Exercise | $37.96 | 2,324 | 88,219 | 54,662 | Jan 08, 2024, 09:13 PM |
| Smith L. Mary | Chief Development Officer | Jan 08, 2024 | Option Exercise | $41.53 | 3,535 | 146,809 | 233,363 | Jan 08, 2024, 09:13 PM |
| Smith L. Mary | Chief Development Officer | Jan 05, 2024 | Option Exercise | $37.96 | 2,197 | 83,398 | 236,898 | Jan 08, 2024, 09:13 PM |
| Islam Saqib | Chief Executive Officer | Jan 08, 2024 | Option Exercise | $41.53 | 17,904 | 743,553 | 256,264 | Jan 08, 2024, 09:12 PM |
| Islam Saqib | Chief Executive Officer | Jan 05, 2024 | Option Exercise | $37.96 | 12,885 | 489,115 | 274,168 | Jan 08, 2024, 09:12 PM |
| Pichl Daniel | Chief People Officer | Jan 08, 2024 | Option Exercise | $41.53 | 1,405 | 58,350 | 55,143 | Jan 08, 2024, 09:12 PM |
| Pichl Daniel | Chief People Officer | Jan 05, 2024 | Option Exercise | $37.96 | 1,574 | 59,749 | 56,548 | Jan 08, 2024, 09:12 PM |
| Perier Francis I Jr | Chief Financial Officer | Jan 08, 2024 | Option Exercise | $41.53 | 3,215 | 133,519 | 59,253 | Jan 08, 2024, 09:11 PM |
| Perier Francis I Jr | Chief Financial Officer | Jan 05, 2024 | Option Exercise | $37.96 | 2,151 | 81,652 | 62,468 | Jan 08, 2024, 09:11 PM |
| Nofi Michael | Chief Accounting Officer | Jan 08, 2024 | Option Exercise | $41.53 | 1,063 | 44,146 | 28,727 | Jan 08, 2024, 09:11 PM |
| Nofi Michael | Chief Accounting Officer | Jan 05, 2024 | Option Exercise | $37.96 | 1,169 | 44,375 | 29,790 | Jan 08, 2024, 09:11 PM |
| Edris Badreddin | Chief Operating Officer | Jan 05, 2024 | Option Exercise | $37.96 | 4,469 | 169,643 | 275,066 | Jan 08, 2024, 09:09 PM |
| Edris Badreddin | Chief Operating Officer | Jan 08, 2024 | Option Exercise | $41.53 | 5,466 | 227,003 | 269,600 | Jan 08, 2024, 09:09 PM |
| Cassidy James | Chief Medical Officer | Jan 08, 2024 | Option Exercise | $41.53 | 1,093 | 45,392 | 76,416 | Jan 08, 2024, 09:07 PM |
| Cassidy James | Chief Medical Officer | Jan 05, 2024 | Option Exercise | $37.96 | 2,357 | 89,472 | 77,509 | Jan 08, 2024, 09:07 PM |
| Ashar Bhavesh | Chief Commercial Officer | Jan 08, 2024 | Option Exercise | $41.53 | 1,449 | 60,177 | 66,210 | Jan 08, 2024, 09:06 PM |
| Ashar Bhavesh | Chief Commercial Officer | Jan 05, 2024 | Option Exercise | $37.96 | 2,507 | 95,166 | 67,659 | Jan 08, 2024, 09:06 PM |
| Cassidy James | Chief Medical Officer | Sep 01, 2023 | Option Exercise | $30.33 | 1,292 | 39,186 | 51,658 | Sep 08, 2023, 04:05 PM |
| Hambleton Julie | Director | Jul 19, 2023 | Sale | $29.31 | 2,418 | 70,876 | 4,648 | Jul 21, 2023, 04:13 PM |
| Hambleton Julie | Director | Jun 20, 2023 | Sale | $26.92 | 2,400 | 64,603 | 7,066 | Jun 22, 2023, 04:06 PM |
| Ashar Bhavesh | Chief Commercial Officer | Apr 03, 2023 | Option Exercise | $25.25 | 1,375 | 34,719 | 43,721 | Apr 05, 2023, 04:46 PM |
| Schwartz Jeffrey Lawrence | Director | Mar 16, 2023 | Sale | $28.50 | 1,750,000 | 49,875,000 | 3,081,307 | Mar 20, 2023, 05:00 PM |
| Hambleton Julie | Director | Mar 15, 2023 | Sale | $31.50 | 1,106 | 34,841 | 4,818 | Mar 16, 2023, 04:31 PM |
| Pichl Daniel | Chief People Officer | Jan 26, 2023 | Sale | $31.00 | 858 | 26,598 | 35,203 | Jan 27, 2023, 04:30 PM |
| Nofi Michael | Chief Accounting Officer | Jan 07, 2023 | Option Exercise | $26.41 | 409 | 10,802 | 16,855 | Jan 10, 2023, 04:08 PM |
| Islam Saqib | Chief Executive Officer | Jan 07, 2023 | Option Exercise | $26.41 | 4,097 | 108,202 | 905,104 | Jan 10, 2023, 04:07 PM |
| Edris Badreddin | Chief Operating Officer | Jan 07, 2023 | Option Exercise | $26.41 | 1,483 | 39,166 | 237,223 | Jan 10, 2023, 04:05 PM |
| Pichl Daniel | Chief People Officer | Jan 07, 2023 | Option Exercise | $26.41 | 546 | 14,420 | 36,061 | Jan 10, 2023, 04:02 PM |
| Perier Francis I Jr | Chief Financial Officer | Jan 07, 2023 | Option Exercise | $26.41 | 1,090 | 28,787 | 43,463 | Jan 10, 2023, 04:02 PM |
| Smith L. Mary | Chief Development Officer | Jan 07, 2023 | Option Exercise | $26.41 | 1,068 | 28,206 | 212,219 | Jan 10, 2023, 04:01 PM |
| Weinstein Herschel S | General Counsel & Secretary | Jan 07, 2023 | Option Exercise | $26.41 | 909 | 24,007 | 35,830 | Jan 10, 2023, 04:01 PM |
| Perier Francis I Jr | Chief Financial Officer | Jan 06, 2023 | Option Exercise | $27.52 | 2,374 | 65,332 | 44,553 | Jan 09, 2023, 05:01 PM |
| Islam Saqib | Chief Executive Officer | Jan 06, 2023 | Option Exercise | $27.52 | 8,400 | 231,168 | 909,201 | Jan 09, 2023, 05:01 PM |
| Edris Badreddin | Chief Operating Officer | Jan 06, 2023 | Option Exercise | $27.52 | 3,326 | 91,532 | 238,706 | Jan 09, 2023, 05:01 PM |
| Cassidy James | Chief Medical Officer | Jan 06, 2023 | Option Exercise | $27.52 | 1,263 | 34,758 | 47,230 | Jan 09, 2023, 05:00 PM |
| Smith L. Mary | Chief Development Officer | Jan 06, 2023 | Option Exercise | $27.52 | 2,452 | 67,479 | 213,287 | Jan 09, 2023, 05:00 PM |
| Nofi Michael | Chief Accounting Officer | Jan 06, 2023 | Option Exercise | $27.52 | 783 | 21,548 | 17,264 | Jan 09, 2023, 05:00 PM |
| Ashar Bhavesh | Chief Commercial Officer | Jan 06, 2023 | Option Exercise | $27.52 | 1,665 | 45,821 | 45,096 | Jan 09, 2023, 05:00 PM |
| Weinstein Herschel S | General Counsel & Secretary | Jan 06, 2023 | Option Exercise | $27.52 | 1,782 | 49,041 | 36,739 | Jan 09, 2023, 04:59 PM |
| Pichl Daniel | Chief People Officer | Jan 06, 2023 | Option Exercise | $27.52 | 1,719 | 47,307 | 36,607 | Jan 09, 2023, 04:59 PM |
| Ashar Bhavesh | Chief Commercial Officer | Apr 01, 2022 | Option Exercise | $56.90 | 1,464 | 83,302 | 24,098 | Oct 13, 2022, 04:03 PM |
| ORBIMED ADVISORS LLC | 10% Owner | Sep 12, 2022 | Sale | $31.96 | 153,897 | 4,919,148 | 5,629,842 | Sep 14, 2022, 04:24 PM |
| ORBIMED ADVISORS LLC | 10% Owner | Aug 09, 2022 | Sale | $37.47 | 69,568 | 2,606,713 | 5,753,739 | Aug 10, 2022, 04:22 PM |
| ORBIMED ADVISORS LLC | 10% Owner | Aug 08, 2022 | Sale | $38.33 | 205,000 | 7,857,650 | 5,823,307 | Aug 10, 2022, 04:22 PM |
| Smith L. Mary | Chief Development Officer | Jul 18, 2022 | Option Exercise | $28.47 | 1,551 | 44,157 | 193,076 | Jul 20, 2022, 06:02 PM |
| Burgess Michael F. | Head of Research & Development | Jul 18, 2022 | Option Exercise | $28.47 | 3,103 | 88,342 | 49,584 | Jul 20, 2022, 06:02 PM |
| Burgess Michael F. | Head of Research & Development | Jun 01, 2022 | Option Exercise | $19.61 | 2,672 | 52,398 | 40,502 | Jul 05, 2022, 05:29 PM |
| Nofi Michael | Chief Accounting Officer | Jan 07, 2022 | Option Exercise | $56.06 | 414 | 23,209 | 8,334 | Jan 14, 2022, 04:59 PM |
| Pichl Daniel | Chief People Officer | Jan 07, 2022 | Option Exercise | $56.06 | 631 | 35,374 | 21,667 | Jan 14, 2022, 04:59 PM |
| Weinstein Herschel S | General Counsel & Secretary | Jan 07, 2022 | Option Exercise | $56.06 | 966 | 54,154 | 19,096 | Jan 14, 2022, 04:58 PM |
| Perier Francis I Jr | Chief Financial Officer | Jan 07, 2022 | Option Exercise | $56.06 | 1,307 | 73,270 | 27,502 | Jan 14, 2022, 04:58 PM |
| Smith L. Mary | Chief Development Officer | Jan 07, 2022 | Option Exercise | $56.06 | 1,181 | 66,207 | 188,535 | Jan 14, 2022, 04:58 PM |
| Edris Badreddin | Chief Operating Officer | Jan 07, 2022 | Option Exercise | $56.06 | 1,852 | 103,823 | 325,813 | Jan 14, 2022, 04:58 PM |
| Islam Saqib | Chief Executive Officer | Jan 07, 2022 | Option Exercise | $56.06 | 3,996 | 224,016 | 853,592 | Jan 14, 2022, 04:57 PM |
| Weinstein Herschel S | General Counsel & Secretary | Jan 07, 2022 | Option Exercise | $56.06 | 1,323 | 74,167 | 18,739 | Jan 11, 2022, 04:04 PM |
| Pichl Daniel | Chief People Officer | Jan 07, 2022 | Option Exercise | $56.06 | 842 | 47,203 | 21,456 | Jan 11, 2022, 04:04 PM |
| Francis Perier I Jr | Chief Financial Officer | Jan 07, 2022 | Option Exercise | $56.06 | 1,846 | 103,487 | 26,963 | Jan 11, 2022, 04:04 PM |
| Nofi Michael | Chief Accounting Officer | Jan 07, 2022 | Option Exercise | $56.06 | 567 | 31,786 | 8,181 | Jan 11, 2022, 04:03 PM |
| Smith L. Mary | Chief Development Officer | Jan 07, 2022 | Option Exercise | $56.06 | 1,772 | 99,338 | 187,944 | Jan 11, 2022, 04:03 PM |
| Islam Saqib | Chief Executive Officer | Jan 07, 2022 | Option Exercise | $56.06 | 5,893 | 330,362 | 851,695 | Jan 11, 2022, 04:02 PM |
| Edris Badreddin | Chief Operating Officer | Jan 07, 2022 | Option Exercise | $56.06 | 2,531 | 141,888 | 325,134 | Jan 11, 2022, 04:02 PM |
| Islam Saqib | Chief Executive Officer | Oct 20, 2021 | Sale | $58.67 | 10,083 | 591,527 | 779,218 | Oct 20, 2021, 07:14 PM |
| Islam Saqib | Chief Executive Officer | Oct 19, 2021 | Sale | $58.81 | 14,077 | 827,873 | 769,135 | Oct 19, 2021, 07:27 PM |
| Islam Saqib | Chief Executive Officer | Oct 18, 2021 | Sale | $58.59 | 38,340 | 2,246,505 | 783,212 | Oct 19, 2021, 07:27 PM |
| Smith L. Mary | Chief Development Officer | Oct 13, 2021 | Option Exercise | $2.30 | 10,000 | 23,000 | 177,511 | Oct 13, 2021, 08:24 PM |
| Smith L. Mary | Chief Development Officer | Oct 13, 2021 | Sale | $55.97 | 10,000 | 559,675 | 167,511 | Oct 13, 2021, 08:24 PM |
| Pichl Daniel | Chief People Officer | Sep 08, 2021 | Option Exercise | $43.10 | 2,320 | 99,992 | 9,236 | Sep 09, 2021, 05:15 PM |
| Bain Capital Life Sciences Investors, LLC | 10% Owner | Aug 10, 2021 | Sale | $70.25 | 1,000,000 | 70,250,000 | 4,831,307 | Aug 12, 2021, 08:38 PM |
| Islam Saqib | Chief Executive Officer | Jul 20, 2021 | Sale | $77.68 | 18,572 | 1,442,751 | 821,552 | Jul 20, 2021, 07:34 PM |
| Islam Saqib | Chief Executive Officer | Jul 19, 2021 | Sale | $76.09 | 43,928 | 3,342,437 | 840,124 | Jul 20, 2021, 07:34 PM |
| Smith L. Mary | Chief Development Officer | Jul 13, 2021 | Option Exercise | $2.30 | 10,000 | 23,000 | 177,511 | Jul 14, 2021, 04:28 PM |
| Smith L. Mary | Chief Development Officer | Jul 13, 2021 | Sale | $80.88 | 10,000 | 808,777 | 167,511 | Jul 14, 2021, 04:28 PM |
| ORBIMED ADVISORS LLC | 10% Owner | Jul 01, 2021 | Sale | $85.01 | 15,959 | 1,356,675 | 6,028,307 | Jul 06, 2021, 04:42 PM |
| Edris Badreddin | Chief Operating Officer | Jul 01, 2021 | Sale | $85.35 | 32,000 | 2,731,088 | 301,541 | Jul 01, 2021, 06:30 PM |
| ORBIMED ADVISORS LLC | 10% Owner | Jun 28, 2021 | Sale | $85.17 | 6,502 | 553,775 | 6,044,266 | Jun 30, 2021, 09:01 PM |
| ORBIMED ADVISORS LLC | 10% Owner | Jun 24, 2021 | Sale | $85.22 | 34,200 | 2,914,524 | 6,073,102 | Jun 25, 2021, 07:11 PM |
| ORBIMED ADVISORS LLC | 10% Owner | Jun 23, 2021 | Sale | $85.00 | 100 | 8,500 | 6,107,302 | Jun 25, 2021, 07:11 PM |
| ORBIMED ADVISORS LLC | 10% Owner | Jun 25, 2021 | Sale | $85.14 | 22,334 | 1,901,517 | 6,050,768 | Jun 25, 2021, 07:11 PM |
| SQUINTO STEPHEN P | Director | Apr 28, 2021 | Sale | $76.20 | 19,231 | 1,465,437 | 125,728 | Apr 28, 2021, 08:18 PM |
| SQUINTO STEPHEN P | Director | Apr 27, 2021 | Sale | $75.05 | 201 | 15,085 | 144,959 | Apr 28, 2021, 08:18 PM |
| Islam Saqib | Chief Executive Officer | Apr 20, 2021 | Sale | $66.39 | 24,075 | 1,598,279 | 884,052 | Apr 20, 2021, 06:51 PM |
| Islam Saqib | Chief Executive Officer | Apr 19, 2021 | Sale | $69.04 | 38,425 | 2,652,827 | 908,127 | Apr 20, 2021, 06:51 PM |
| SQUINTO STEPHEN P | Director | Apr 14, 2021 | Sale | $75.08 | 511 | 38,365 | 146,217 | Apr 19, 2021, 06:07 AM |
| SQUINTO STEPHEN P | Director | Apr 15, 2021 | Sale | $75.01 | 1,057 | 79,291 | 145,160 | Apr 19, 2021, 06:07 AM |
| Smith L. Mary | Chief Development Officer | Apr 13, 2021 | Option Exercise | $2.30 | 10,000 | 23,000 | 177,511 | Apr 13, 2021, 08:21 PM |
| Smith L. Mary | Chief Development Officer | Apr 13, 2021 | Sale | $68.07 | 10,000 | 680,723 | 167,511 | Apr 13, 2021, 08:21 PM |
| Bain Capital Life Sciences Investors, LLC | 10% Owner | Mar 09, 2021 | Sale | $71.50 | 1,450,000 | 103,675,000 | 5,831,307 | Mar 11, 2021, 04:30 PM |
| ORBIMED ADVISORS LLC | 10% Owner | Mar 01, 2021 | Sale | $83.19 | 1,220,000 | 101,491,803 | 6,186,307 | Mar 03, 2021, 06:55 PM |
| Edris Badreddin | Chief Operating Officer | Jan 25, 2021 | Sale | $84.07 | 32,000 | 2,690,281 | 261,542 | Jan 26, 2021, 04:31 PM |
| Smith L. Mary | Chief Development Officer | Jan 20, 2021 | Option Exercise | $2.23 | 10,000 | 22,267 | 177,511 | Jan 21, 2021, 04:31 PM |
| Smith L. Mary | Chief Development Officer | Jan 20, 2021 | Sale | $78.70 | 10,000 | 787,016 | 167,511 | Jan 21, 2021, 04:31 PM |
| Islam Saqib | Chief Executive Officer | Jan 20, 2021 | Sale | $78.75 | 2,199 | 173,180 | 1,222,997 | Jan 21, 2021, 04:30 PM |
| Islam Saqib | Chief Executive Officer | Jan 19, 2021 | Sale | $78.54 | 60,301 | 4,736,209 | 1,225,196 | Jan 21, 2021, 04:30 PM |
| Lewis-Hall Freda C | Director | Sep 17, 2019 | Buy | $18.00 | 50,000 | 900,000 | 4,593,847 | Sep 19, 2019, 07:12 PM |
| ORBIMED ADVISORS LLC | 10% Owner | Sep 17, 2019 | Buy | $18.00 | 275,000 | 4,950,000 | 7,406,307 | Sep 19, 2019, 07:12 PM |
| SQUINTO STEPHEN P | Director | Sep 17, 2019 | Buy | $18.00 | 275,000 | 4,950,000 | 7,406,307 | Sep 19, 2019, 07:12 PM |
| Bain Capital Life Sciences Investors, LLC | 10% Owner | Sep 17, 2019 | Buy | $18.00 | 150,000 | 2,700,000 | 7,281,307 | Sep 19, 2019, 07:05 PM |
| PFIZER INC | 10% Owner | Sep 17, 2019 | Buy | $18.00 | 50,000 | 900,000 | 4,593,847 | Sep 19, 2019, 04:19 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Ashar Bhavesh | Chief Commercial Officer | 04/01/2024 | 86,859 |
| Pichl Daniel | Chief People Officer | 02/16/2024 | 414,600 |
| Pichl Daniel | Chief People Officer | 02/16/2024 | 751,549 |
| Ashar Bhavesh | Chief Commercial Officer | 02/05/2024 | 238,435 |
| Ashar Bhavesh | Chief Commercial Officer | 02/02/2024 | 142,976 |
| Pichl Daniel | Chief People Officer | 02/02/2024 | 449,150 |
| Pichl Daniel | Chief People Officer | 02/02/2024 | 1,160,362 |
| Weinstein Herschel S | General Counsel & Secretary | 01/08/2024 | 100,627 |
| Weinstein Herschel S | General Counsel & Secretary | 01/05/2024 | 88,219 |
| Smith L. Mary | Chief Development Officer | 01/08/2024 | 146,809 |
| Smith L. Mary | Chief Development Officer | 01/05/2024 | 83,398 |
| Islam Saqib | Chief Executive Officer | 01/08/2024 | 743,553 |
| Islam Saqib | Chief Executive Officer | 01/05/2024 | 489,115 |
| Pichl Daniel | Chief People Officer | 01/08/2024 | 58,350 |
| Pichl Daniel | Chief People Officer | 01/05/2024 | 59,749 |
| Perier Francis I Jr | Chief Financial Officer | 01/08/2024 | 133,519 |
| Perier Francis I Jr | Chief Financial Officer | 01/05/2024 | 81,652 |
| Nofi Michael | Chief Accounting Officer | 01/08/2024 | 44,146 |
| Nofi Michael | Chief Accounting Officer | 01/05/2024 | 44,375 |
| Edris Badreddin | Chief Operating Officer | 01/05/2024 | 169,643 |
| Edris Badreddin | Chief Operating Officer | 01/08/2024 | 227,003 |
| Cassidy James | Chief Medical Officer | 01/08/2024 | 45,392 |
| Cassidy James | Chief Medical Officer | 01/05/2024 | 89,472 |
| Ashar Bhavesh | Chief Commercial Officer | 01/08/2024 | 60,177 |
| Ashar Bhavesh | Chief Commercial Officer | 01/05/2024 | 95,166 |
| Cassidy James | Chief Medical Officer | 09/01/2023 | 39,186 |
| Hambleton Julie | Director | 07/19/2023 | 70,876 |
| Hambleton Julie | Director | 06/20/2023 | 64,603 |
| Ashar Bhavesh | Chief Commercial Officer | 04/03/2023 | 34,719 |
| Schwartz Jeffrey Lawrence | Director | 03/16/2023 | 49,875,000 |
| Hambleton Julie | Director | 03/15/2023 | 34,841 |
| Pichl Daniel | Chief People Officer | 01/26/2023 | 26,598 |
| Nofi Michael | Chief Accounting Officer | 01/07/2023 | 10,802 |
| Islam Saqib | Chief Executive Officer | 01/07/2023 | 108,202 |
| Edris Badreddin | Chief Operating Officer | 01/07/2023 | 39,166 |
| Pichl Daniel | Chief People Officer | 01/07/2023 | 14,420 |
| Perier Francis I Jr | Chief Financial Officer | 01/07/2023 | 28,787 |
| Smith L. Mary | Chief Development Officer | 01/07/2023 | 28,206 |
| Weinstein Herschel S | General Counsel & Secretary | 01/07/2023 | 24,007 |
| Perier Francis I Jr | Chief Financial Officer | 01/06/2023 | 65,332 |
| Islam Saqib | Chief Executive Officer | 01/06/2023 | 231,168 |
| Edris Badreddin | Chief Operating Officer | 01/06/2023 | 91,532 |
| Cassidy James | Chief Medical Officer | 01/06/2023 | 34,758 |
| Smith L. Mary | Chief Development Officer | 01/06/2023 | 67,479 |
| Nofi Michael | Chief Accounting Officer | 01/06/2023 | 21,548 |
| Ashar Bhavesh | Chief Commercial Officer | 01/06/2023 | 45,821 |
| Weinstein Herschel S | General Counsel & Secretary | 01/06/2023 | 49,041 |
| Pichl Daniel | Chief People Officer | 01/06/2023 | 47,307 |
| Ashar Bhavesh | Chief Commercial Officer | 04/01/2022 | 83,302 |
| ORBIMED ADVISORS LLC | 10% Owner | 09/12/2022 | 4,919,148 |
| ORBIMED ADVISORS LLC | 10% Owner | 08/09/2022 | 2,606,713 |
| ORBIMED ADVISORS LLC | 10% Owner | 08/08/2022 | 7,857,650 |
| Smith L. Mary | Chief Development Officer | 07/18/2022 | 44,157 |
| Burgess Michael F. | Head of Research & Development | 07/18/2022 | 88,342 |
| Burgess Michael F. | Head of Research & Development | 06/01/2022 | 52,398 |
| Nofi Michael | Chief Accounting Officer | 01/07/2022 | 23,209 |
| Pichl Daniel | Chief People Officer | 01/07/2022 | 35,374 |
| Weinstein Herschel S | General Counsel & Secretary | 01/07/2022 | 54,154 |
| Perier Francis I Jr | Chief Financial Officer | 01/07/2022 | 73,270 |
| Smith L. Mary | Chief Development Officer | 01/07/2022 | 66,207 |
| Edris Badreddin | Chief Operating Officer | 01/07/2022 | 103,823 |
| Islam Saqib | Chief Executive Officer | 01/07/2022 | 224,016 |
| Weinstein Herschel S | General Counsel & Secretary | 01/07/2022 | 74,167 |
| Pichl Daniel | Chief People Officer | 01/07/2022 | 47,203 |
| Francis Perier I Jr | Chief Financial Officer | 01/07/2022 | 103,487 |
| Nofi Michael | Chief Accounting Officer | 01/07/2022 | 31,786 |
| Smith L. Mary | Chief Development Officer | 01/07/2022 | 99,338 |
| Islam Saqib | Chief Executive Officer | 01/07/2022 | 330,362 |
| Edris Badreddin | Chief Operating Officer | 01/07/2022 | 141,888 |
| Islam Saqib | Chief Executive Officer | 10/20/2021 | 591,527 |
| Islam Saqib | Chief Executive Officer | 10/19/2021 | 827,873 |
| Islam Saqib | Chief Executive Officer | 10/18/2021 | 2,246,505 |
| Smith L. Mary | Chief Development Officer | 10/13/2021 | 23,000 |
| Smith L. Mary | Chief Development Officer | 10/13/2021 | 559,675 |
| Pichl Daniel | Chief People Officer | 09/08/2021 | 99,992 |
| Bain Capital Life Sciences Investors, LLC | 10% Owner | 08/10/2021 | 70,250,000 |
| Islam Saqib | Chief Executive Officer | 07/20/2021 | 1,442,751 |
| Islam Saqib | Chief Executive Officer | 07/19/2021 | 3,342,437 |
| Smith L. Mary | Chief Development Officer | 07/13/2021 | 23,000 |
| Smith L. Mary | Chief Development Officer | 07/13/2021 | 808,777 |
| ORBIMED ADVISORS LLC | 10% Owner | 07/01/2021 | 1,356,675 |
| Edris Badreddin | Chief Operating Officer | 07/01/2021 | 2,731,088 |
| ORBIMED ADVISORS LLC | 10% Owner | 06/28/2021 | 553,775 |
| ORBIMED ADVISORS LLC | 10% Owner | 06/24/2021 | 2,914,524 |
| ORBIMED ADVISORS LLC | 10% Owner | 06/23/2021 | 8,500 |
| ORBIMED ADVISORS LLC | 10% Owner | 06/25/2021 | 1,901,517 |
| SQUINTO STEPHEN P | Director | 04/28/2021 | 1,465,437 |
| SQUINTO STEPHEN P | Director | 04/27/2021 | 15,085 |
| Islam Saqib | Chief Executive Officer | 04/20/2021 | 1,598,279 |
| Islam Saqib | Chief Executive Officer | 04/19/2021 | 2,652,827 |
| SQUINTO STEPHEN P | Director | 04/14/2021 | 38,365 |
| SQUINTO STEPHEN P | Director | 04/15/2021 | 79,291 |
| Smith L. Mary | Chief Development Officer | 04/13/2021 | 23,000 |
| Smith L. Mary | Chief Development Officer | 04/13/2021 | 680,723 |
| Bain Capital Life Sciences Investors, LLC | 10% Owner | 03/09/2021 | 103,675,000 |
| ORBIMED ADVISORS LLC | 10% Owner | 03/01/2021 | 101,491,803 |
| Edris Badreddin | Chief Operating Officer | 01/25/2021 | 2,690,281 |
| Smith L. Mary | Chief Development Officer | 01/20/2021 | 22,267 |
| Smith L. Mary | Chief Development Officer | 01/20/2021 | 787,016 |
| Islam Saqib | Chief Executive Officer | 01/20/2021 | 173,180 |
| Islam Saqib | Chief Executive Officer | 01/19/2021 | 4,736,209 |
| Lewis-Hall Freda C | Director | 09/17/2019 | 900,000 |
| ORBIMED ADVISORS LLC | 10% Owner | 09/17/2019 | 4,950,000 |
| SQUINTO STEPHEN P | Director | 09/17/2019 | 4,950,000 |
| Bain Capital Life Sciences Investors, LLC | 10% Owner | 09/17/2019 | 2,700,000 |
| PFIZER INC | 10% Owner | 09/17/2019 | 900,000 |
Load More Insider Transactions
FUNDS WITH A POSITION IN SPRINGWORKS THERAPEUTICS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BLACKROCK INC. | 5,382,184 | 0.00501% | 21.61% | Other |
| ORBIMED ADVISORS LLC | 3,219,359 | 2.35% | -18.88% | Other |
| MAVERICK CAPITAL LTD | 2,873,216 | 2.11% | 350.52% | Growth At A Reasonable Price, Growth |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,584,376 | 1.74% | 63.61% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 1,419,088 | 0.00542% | 20.05% | Other |
| CANDRIAM S.C.A. | 275,628 | 0.07% | 82.99% | Other |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 136,624 | 0.06% | -74.43% | Growth |
| D. E. SHAW & CO., INC. | 130,312 | 0.00416% | 23.24% | Other |
| UBS OCONNOR LLC | 75,250 | 0.2% | -19.29% | Value |
| BLACKSTONE INC. | 75,000 | 0.01% | New | Other |
| ALPS ADVISORS INC | 41,333 | 0.01% | -10.55% | Other |
| UBS OCONNOR LLC | 30,000 (Call) | 0.00712% | New | Value |
| TUDOR INVESTMENT CORP ET AL | 19,073 | 0.00561% | New | Event Driven, Other |
CHANGE IN SHARES OUTSTANDING FOR SPRINGWORKS THERAPEUTICS INC
STOCK BUYBACKS FOR SPRINGWORKS THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
4.50%
1Q
06/30/2023
4.60%
2Q
03/31/2023
4.83%
3Q
12/31/2022
4.93%
4Q
09/30/2022
23.51%
5Q
06/30/2022
33.14%
6Q
03/31/2022
33.51%
7Q
12/31/2021
34.05%
8Q
09/30/2021
34.45%
9Q
06/30/2021
34.93%
10Q
03/31/2021
35.47%
11Q
12/31/2020
38.09%
12Q
09/30/2020
55.01%
13Q
06/30/2020
55.77%
14Q
03/31/2020
56.35%
15Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR SPRINGWORKS THERAPEUTICS INC
LOADING...